Cancer Research
RECNAC ,
Fatty Acid ,
Lipoic-Acid ,
Natural Extracts ,
Bindweed ,
LF Bacterium
Anticancer Effect of Natural Organism Extracts:
The natural organisms include plants, bacteria and invertebrate. The purpose of this study is to find a high effective but low toxic anticancer agent.
Here is how we did the study. The natural organisms are minced and soaked by buffers or solvents. After precipitation, centrifugation, filtration and lyophilization, we get a crude extract. The crude extract will be analyzed by spectrophotometry, chromatography, electrophoresis, etc.
 
|
It will be tested on cultured cells for cytotoxicity, on eggs for angiogenesis, on animal models for tumor inhibition. If the crude extract shows good results, we may separate it by the polarity, size and charge of the molecules and repeat the analysis and the above tests until we get the high effective and low toxic anticancer agent. |
 
|
This slide shows the differential cytotoxicity of an invertebrate extract on normal and tumor cells. CCD is a colon normal cell line. LS is a colon cancer cell line. The others are tumor cell lines too. Y axis is the cell growth rate. The invertebrate extract kills tumor cells 15 times more than normal cells. This is one way that we look for the effective molecules in vitro: the high differential cytotoxicity. |
 
| This slide shows the dose responses of a plant extract on sarcoma and lung cancer cell lines. The upper left is the sarcoma cells. The lower right is the lung cancer cells. X axis is the dose, µg/ml. Y axis is the cell growth inhibition. This plant extract is toxic only at very high concentration, 1000 or 2000 µg/ml, while the chemotherapeutic agents are usually less than 10 µg/ml. |
The tumor inhibition of this extract on animal test (70-80%) was definitely not due to the direct tumor toxicity. This fit our critearia of high effect and low toxicity.
 
|
This slide shows the angiogenesis inhibition in cultured cells. Angiogenesis means new blood vessel starting and growing. It happens around all malignent
tumors. If any drug can inhibit the angiogenesis around a tumor,
it may stop the growth and metastasis of the tumor. |
Capillary blood vessels consist of endothelium cells. ECV304 is an
endothelium cell line. An agent that inhibit ECV304 cells in vitro may inhibit
angiogenesis in vivo. At 10 µg/ml level, one of our bacterium extract showed 60% inhibitio and a good dose response. In the literature, 30% inhibition was a good one for the angiogenesis inhibition at 10 µg/ml level.
Cell culture is a fast but indirect experiment for studying angiogenesis. Using the fertilized eggs, we can see the angiogenesis and its inhibition directly.
The left picture of this slide shows the HT1080 cell induced tumor and angiogenesis around the tumor. The right picture shows the tumor and angiogenesis inhibition of one of our invertebrate extract. The tumor was much smaller. The blood vessels was less.
In treating groups, due to the anticancer agents, the tumors were much smaller. For the sarcoma model, the tumor inhibition is 77%. For the lung cancer, the inhibition is 62%. For the melanoma, the inhibition is 53%. On these animal models, tumors grow very fast. In two or three weeks, the tumor can grow 8-10% of the body weight. If a tested agent can reach 30-40% tumor inhibition on these models, it will be considered a hopeful anticancer agent. Some of our agents reached more than 80%.
These extracts showed not only very high tumor inhibition, but also low toxicity. The left chart of this slide shows the tumor inhibition of a bacterium extract on the sarcoma model. The tumor inhibition was 77%. The right chart of this slide shows the comparison of the toxic and treating dosages.
|
|
|
|
|
|
|